<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Oncology on FinanClub</title>
    <link>https://finan.club/tags/oncology/</link>
    <description>Recent content in Oncology on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 16 Jan 2024 09:06:16 +0000</lastBuildDate><atom:link href="https://finan.club/tags/oncology/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>MRK</title>
      <link>https://finan.club/us/mrk/</link>
      <pubDate>Tue, 16 Jan 2024 09:06:16 +0000</pubDate>
      
      <guid>https://finan.club/us/mrk/</guid>
      <description>score:35
Chances: Merck &amp;amp; Co. continues to show positive trend in veterinarian practices and support for U.S. veterinarians and support teams. The FDA approval for expanded use of Keytruda in combination with chemoradiotherapy to treat advanced cervical cancer is a significant development for Merck &amp;amp; Co.</description>
    </item>
    
  </channel>
</rss>
